Coldstream Capital Management Inc Bio Rad Laboratories, Inc. Transaction History

Coldstream Capital Management Inc

  • $4.58 Billion
  • Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 848 shares of BIO stock, worth $280,289. This represents 0.01% of its overall portfolio holdings.

Number of Shares
848
Previous 828 2.42%
Holding current value
$280,289
Previous $226,000 25.22%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$263.97 - $344.64 $5,279 - $6,892
20 Added 2.42%
848 $283,000
Q2 2024

Aug 07, 2024
SELL
$268.26 - $339.48 $6,438 - $8,147
-24 Reduced 2.82%
828 $226,000
Q1 2024

May 13, 2024
SELL
$304.11 - $351.99 $87,583 - $101,373
-288 Reduced 25.26%
852 $294,000
Q4 2023

Feb 09, 2024
BUY
$269.37 - $365.04 $129,297 - $175,219
480 Added 72.73%
1,140 $368,000
Q3 2023

Nov 02, 2023
SELL
$350.25 - $422.63 $12,609 - $15,214
-36 Reduced 5.17%
660 $236,000
Q2 2023

Aug 03, 2023
BUY
$359.49 - $486.4 $21,569 - $29,184
60 Added 9.43%
696 $263,000
Q1 2023

May 15, 2023
SELL
$418.69 - $503.0 $1,674 - $2,012
-4 Reduced 0.63%
636 $304,000
Q4 2022

Jan 10, 2023
BUY
$351.71 - $456.01 $17,585 - $22,800
50 Added 8.47%
640 $0
Q2 2022

Aug 08, 2022
SELL
$463.67 - $597.16 $201,232 - $259,167
-434 Closed
0 $0
Q2 2022

Aug 08, 2022
BUY
$463.67 - $597.16 $273,565 - $352,324
590 New
590 $292,000
Q1 2022

May 11, 2022
SELL
$524.57 - $735.42 $79,210 - $111,048
-151 Reduced 25.81%
434 $244,000
Q4 2021

Feb 11, 2022
BUY
$708.84 - $794.68 $414,671 - $464,887
585 New
585 $442,000
Q3 2020

Nov 16, 2020
SELL
$454.43 - $535.6 $298,560 - $351,889
-657 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$334.87 - $493.06 $11,720 - $17,257
-35 Reduced 5.06%
657 $296,000
Q1 2020

May 27, 2020
SELL
$320.01 - $409.07 $34,881 - $44,588
-109 Reduced 13.61%
692 $242,000
Q4 2019

Feb 13, 2020
BUY
$319.73 - $374.2 $959 - $1,122
3 Added 0.38%
801 $297,000
Q2 2019

Aug 15, 2019
BUY
$286.93 - $312.59 $7,173 - $7,814
25 Added 3.23%
798 $250,000
Q1 2019

May 10, 2019
BUY
$224.3 - $317.41 $173,383 - $245,357
773 New
773 $237,000
Q4 2018

Feb 26, 2019
SELL
$220.1 - $309.0 $188,845 - $265,122
-858 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $248,202 - $279,836
858 New
858 $269,000

Others Institutions Holding BIO

# of Institutions
456
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.14B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email